Jolie Ringash, MD, MSc, FRCPC

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

https://orcid.org/0000-0002-7337-0411
Keywords: radiation therapy, gastrointestinal cancer, intensity-modulated radiotherapy, clinical trials, quality of life
  • Upper abdominal organ motion
  • Cancer survivorship
  • Quality of life in patients with enteral feeding tubes
  • Quality of life issues for patients with head and neck cancers: hyperfractionated/accelerated radiation therapy and chemoradiation therapy
  • Adjuvant therapy for stomach cancer
  • Intensity-modulated radiation therapy for stomach cancer

Related Links

Associated Program(s)
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Radiother Oncol. 2019 May;134:10-16
Hosni A, Huang SH, Chiu K, Xu W, Su J, Lu L, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Int J Radiat Oncol Biol Phys. 2019 Apr 04;:
Billfalk-Kelly A, Yu E, Su J, O'Sullivan B, Waldron J, Ringash J, Bartlett E, Perez-Ordonez B, Weinreb I, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Hansen AR, de Almeida J, Tong L, Xu W, Huang SH
Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer.
Curr Oncol. 2018 Dec;25(6):366-370
Natori A, Chan BA, Sim HW, Ma L, Yokom DW, Chen E, Liu G, Darling G, Swallow C, Brar S, Brierley J, Ringash J, Wong R, Kim J, Rogalla P, Hafezi-Bakhtiari S, Conner J, Knox J, Elimova E, Jang RW
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Lancet. 2018 Nov 15;:
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan...
Impact of neoadjuvant radiation on margins for non-squamous cell carcinoma sinonasal malignancies.
Laryngoscope. 2018 Oct 16;:
Fu T, Chin CJ, Xu W, Che J, Huang SH, Monteiro E, Alghonaim Y, Ringash J, Witterick IJ
A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
Radiother Oncol. 2018 Sep 29;:
McDowell LJ, Ringash J, Xu W, Chan B, Lu L, Waldron J, Rock K, So N, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Bernstein LJ
Predictors of early recurrence prior to planned post-operative radiation therapy for oral cavity squamous cell carcinoma and outcomes following salvage intensified radiation therapy.
Int J Radiat Oncol Biol Phys. 2018 Sep 20;:
Hosni A, Huang SH, Chiu K, Xu W, Su J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, Yu E, de Almeida JR, Monteiro E, Chepeha DB, Irish JC, Goldstein DP, Hope A
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2018 Oct 01;102(2):340-352
McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, Ezzat S, Pothier D, Bernstein LJ, So N, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J
The prevalence and determinants of return to work in head and neck cancer survivors.
Support Care Cancer. 2018 Jul 16;:
Giuliani M, Papadakos J, Broadhurst M, Jones J, McQuestion M, Le LW, Beck L, Waldron J, Ringash J
Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review.
J Thorac Cardiovasc Surg. 2018 Aug;156(2):847-856
Gupta V, Coburn N, Kidane B, Hess KR, Compton C, Ringash J, Darling G, Mahar AL

Pages


 

Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre

Professor, Department of Radiation Oncology, University of Toronto
Professor, Department of Health Policy, Management & Evaluation, University of Toronto
Staff Radiation Oncologist, Princess Margaret Hospital